These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 15464472

  • 1. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE, Rundall BK, Keller MD, Jones DR.
    Ann Thorac Surg; 2004 Oct; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [Abstract] [Full Text] [Related]

  • 2. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
    Duan J, Friedman J, Nottingham L, Chen Z, Ara G, Van Waes C.
    Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
    [Abstract] [Full Text] [Related]

  • 3. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
    [Abstract] [Full Text] [Related]

  • 4. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line.
    Mortenson MM, Schlieman MG, Virudachalam S, Bold RJ.
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):343-53. PubMed ID: 15197486
    [Abstract] [Full Text] [Related]

  • 5. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
    Mol Cancer; 2011 Aug 16; 10():98. PubMed ID: 21843371
    [Abstract] [Full Text] [Related]

  • 6. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    Denlinger CE, Rundall BK, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Nov 16; 128(5):740-8. PubMed ID: 15514602
    [Abstract] [Full Text] [Related]

  • 7. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
    Karthik S, Sankar R, Varunkumar K, Anusha C, Ravikumar V.
    Biomed Pharmacother; 2015 Feb 16; 69():337-44. PubMed ID: 25661379
    [Abstract] [Full Text] [Related]

  • 8. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
    Bhalla S, Balasubramanian S, David K, Sirisawad M, Buggy J, Mauro L, Prachand S, Miller R, Gordon LI, Evens AM.
    Clin Cancer Res; 2009 May 15; 15(10):3354-65. PubMed ID: 19417023
    [Abstract] [Full Text] [Related]

  • 9. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.
    Tang ZY, Wu YL, Gao SL, Shen HW.
    J Surg Res; 2008 Mar 15; 145(1):111-23. PubMed ID: 17714734
    [Abstract] [Full Text] [Related]

  • 10. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
    Tamatani T, Takamaru N, Hara K, Kinouchi M, Kuribayashi N, Ohe G, Uchida D, Fujisawa K, Nagai H, Miyamoto Y.
    Int J Oncol; 2013 Mar 15; 42(3):935-44. PubMed ID: 23340716
    [Abstract] [Full Text] [Related]

  • 11. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.
    Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Apr 15; 127(4):1078-86. PubMed ID: 15052205
    [Abstract] [Full Text] [Related]

  • 12. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.
    Voortman J, Resende TP, Abou El Hassan MA, Giaccone G, Kruyt FA.
    Mol Cancer Ther; 2007 Jul 15; 6(7):2103-12. PubMed ID: 17620439
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.
    Jones DR, Broad RM, Madrid LV, Baldwin AS, Mayo MW.
    Ann Thorac Surg; 2000 Sep 15; 70(3):930-6; discussion 936-7. PubMed ID: 11016336
    [Abstract] [Full Text] [Related]

  • 14. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
    Karthik S, Sankar R, Varunkumar K, Ravikumar V.
    Biomed Pharmacother; 2014 Apr 15; 68(3):327-34. PubMed ID: 24485799
    [Abstract] [Full Text] [Related]

  • 15. Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.
    Chen Z, Ricker JL, Malhotra PS, Nottingham L, Bagain L, Lee TL, Yeh NT, Van Waes C.
    Mol Cancer Ther; 2008 Jul 15; 7(7):1949-60. PubMed ID: 18645005
    [Abstract] [Full Text] [Related]

  • 16. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
    Wissniowski TT, Meister S, Hahn EG, Kalden JR, Voll R, Ocker M.
    Int J Oncol; 2012 May 15; 40(5):1581-9. PubMed ID: 22266985
    [Abstract] [Full Text] [Related]

  • 17. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
    Zou P, Kawada J, Pesnicak L, Cohen JI.
    J Virol; 2007 Sep 15; 81(18):10029-36. PubMed ID: 17626072
    [Abstract] [Full Text] [Related]

  • 18. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2004 Aug 15; 136(2):416-25. PubMed ID: 15300209
    [Abstract] [Full Text] [Related]

  • 19. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
    Hideshima T, Ikeda H, Chauhan D, Okawa Y, Raje N, Podar K, Mitsiades C, Munshi NC, Richardson PG, Carrasco RD, Anderson KC.
    Blood; 2009 Jul 30; 114(5):1046-52. PubMed ID: 19436050
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
    Juvekar A, Manna S, Ramaswami S, Chang TP, Vu HY, Ghosh CC, Celiker MY, Vancurova I.
    Mol Cancer Res; 2011 Feb 30; 9(2):183-94. PubMed ID: 21224428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.